Volume | 16,315 |
|
|||||
News | - | ||||||
Day High | 1.06 | Low High |
|||||
Day Low | 1.0165 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Zentek Ltd | ZTEK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.02 | 1.0165 | 1.06 | 1.03 | 1.0199 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
119 | 16,315 | US$ 1.03 | US$ 16,860 | - | 0.974999 - 1.7494 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:52:10 | 50 | US$ 1.10 | USD |
Zentek Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
140.14M | 100.82M | - | 73k | -14.41M | -0.14 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Zentek News
Date | Time | Source | News Article |
---|---|---|---|
8/24/2023 | 09:20 | AllPennyStocks.com | Healthcare Shares Bid Up Following New Distribution And.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZTEK Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.09 | 1.16 | 1.00 | 1.04 | 22,087 | -0.06 | -5.50% |
1 Month | 1.25 | 1.25 | 1.00 | 1.10 | 18,263 | -0.22 | -17.60% |
3 Months | 1.43 | 1.4591 | 1.00 | 1.21 | 19,798 | -0.40 | -27.97% |
6 Months | 1.28 | 1.59 | 0.974999 | 1.21 | 22,461 | -0.25 | -19.53% |
1 Year | 1.49 | 1.7494 | 0.974999 | 1.32 | 21,328 | -0.46 | -30.87% |
3 Years | 3.00 | 3.78 | 0.974999 | 2.54 | 55,357 | -1.97 | -65.67% |
5 Years | 3.00 | 3.78 | 0.974999 | 2.54 | 55,357 | -1.97 | -65.67% |
Zentek Description
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment.?It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology. |